Browse 24936 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
June 29th, 2021 |
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Black Children and Adolescents (R01 Clinical Trial Optional) |
National Institutes of Health |
October 16th, 2021 |
Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R21 Clinical Trial Optional) |
National Institutes of Health |
June 11th, 2021 |
Building Interdisciplinary Research Careers in Women's Health Program (BIRCWH) (K12 Clinical Trial Optional) |
National Institutes of Health |
June 29th, 2021 |
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional) |
National Institutes of Health |
June 29th, 2021 |
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional) |
National Institutes of Health |
May 28th, 2021 |
U.S. Embassy Nouakchott, PAS Request for Statements of Interest: Annual Program Statement |
US Mission to Mauritania |
July 29th, 2021 |
Biomarker Research to Support Fertility Regulation Development by Small Business (R43 Clinical Trial Optional) |
National Institutes of Health |
August 12th, 2021 |
State, Local, Territorial, and Tribal (SLTT) Partnership Programs to Reduce Maternal Deaths due to Violence |
Office of the Assistant Secretary for Health |
December 31st, 2021 |
Annual Program Statement 2021 |
US Mission to India |
January 29th, 2024 |
Enhancing NIDCD's Extramural Workforce Diversity through Research Experiences (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
August 17th, 2021 |
Promoting Vaccine Confidence in Local Communities through Partnership with Regional Health Offices |
Office of the Assistant Secretary for Health |
November 22nd, 2021 |
3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed) |
National Institutes of Health |
June 24th, 2021 |
Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required) |
National Institutes of Health |
July 7th, 2021 |
Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional) |
National Institutes of Health |
July 7th, 2021 |
Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional) |
National Institutes of Health |
April 29th, 2021 |
Osra (Family) Activity |
Egypt USAID Cairo |
June 11th, 2021 |
NIMHD Multiple Chronic Disease Disparities Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
May 31st, 2021 |
U.S. Ambassador's President's Emergency Plan for AIDS Relief (PEPFAR) Small Grants Program Financial Year (FY) 2021 - 022 |
US Mission to Malawi |
July 29th, 2021 |
Population Dynamics Centers Research Infrastructure Program FY 2022 (P2C Clinical Trial Not Allowed) |
National Institutes of Health |
May 4th, 2021 |
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 |
National Institutes of Health |
|
July 29th, 2021 |
Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2022 (R24 Clinical Trial Not Allowed) |
National Institutes of Health |
July 31st, 2021 |
PEPFAR Grants for Community-Led Monitoring |
US Mission to Nigeria |
May 21st, 2021 |
Rural Residency Planning and Development Technical Assistance Program |
Health Resources and Services Administration |
July 20th, 2021 |
Centers on Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required) |
National Institutes of Health |
September 27th, 2023 |
National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) |
National Institutes of Health |
June 9th, 2021 |
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
August 10th, 2021 |
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R41/R42 - Clinical Trial Not Allowed) |
National Institutes of Health |
October 24th, 2023 |
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2024 |
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required) |
National Institutes of Health |
April 29th, 2021 |
Local Works in the Kyrgyz Republic |
Kazakhstan USAID Almaty |
August 4th, 2021 |
Limited Interaction Targeted Epidemiology (LITE-2): To Advance HIV Prevention (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
July 30th, 2021 |
Understanding HIV Reservoir Dynamics (P01, Clinical Trial Not Allowed) |
National Institutes of Health |
August 10th, 2021 |
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed) |
National Institutes of Health |
April 23rd, 2021 |
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
October 20th, 2021 |
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) |
National Institutes of Health |
January 26th, 2022 |
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional) |
National Institutes of Health |
September 15th, 2021 |
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trial Required) |
National Institutes of Health |
May 20th, 2021 |
Community Engaged Research on Pregnancy Related and Associated Infections and Sepsis Morbidity and Mortality (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
June 1st, 2021 |
Public Diplomacy Grants in Kuwait |
US Mission to Kuwait |
May 17th, 2021 |
Screening and Interventions for Adverse Childhood Experiences in Primary Care Settings Demonstration Project |
Health Resources and Services Administration |